ROME THERAPEUTICS
Live / Registered — Registered (as of 17 Feb 2026)
What this means for you
Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97187984
- Registration number
- 8145678
- Mark type
- Word mark
- Filed
- 23 Dec 2021
- Published for opposition
- 10 Dec 2024
- Registered
- 17 Feb 2026
- Attorney of record
- GLENN A GUNDERSEN
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of cancer and autoimmune disease; pharmaceutical drug development and discovery services in the field of cancer and autoimmune disease; scientific research in the field of pharmaceuticals; providing scientific research information in the field of pharmaceuticals; none of the foregoing relating to gastrointestinal issues
Owner
- ROME Therapeutics, Inc., Boston, MA, US
- ROME Therapeutics, Inc., Boston, MA, US
- ROME Therapeutics, Inc., Boston, MA, US
Prosecution history
- 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 26 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jul 2025 — USE AMENDMENT FILED
- 21 Jan 2026 — SOU EXTENSION 2 GRANTED
- 30 Jul 2025 — SOU EXTENSION 2 FILED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 Jul 2025 — SOU EXTENSION 1 GRANTED
- 30 Jul 2025 — SOU EXTENSION 1 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT